Cardinal Health, Inc. (0HTG.L)
USD 125.54
(-0.31%)
USD 125.54
(-0.31%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 48.33 Billion USD | 4.46% |
| 2023 | 46.26 Billion USD | 3.78% |
| 2022 | 44.58 Billion USD | 4.51% |
| 2021 | 42.65 Billion USD | 9.46% |
| 2020 | 38.97 Billion USD | 12.53% |
| 2019 | 34.63 Billion USD | 2.19% |
| 2018 | 33.89 Billion USD | 1.83% |
| 2017 | 33.28 Billion USD | 20.81% |
| 2016 | 27.55 Billion USD | 15.34% |
| 2015 | 23.88 Billion USD | 21.67% |
| 2014 | 19.63 Billion USD | -1.07% |
| 2013 | 19.84 Billion USD | 10.15% |
| 2012 | 18.01 Billion USD | 5.99% |
| 2011 | 16.99 Billion USD | 15.52% |
| 2010 | 14.71 Billion USD | -10.25% |
| 2009 | 16.39 Billion USD | 4.42% |
| 2008 | 15.7 Billion USD | -0.48% |
| 2007 | 15.77 Billion USD | 6.0% |
| 2006 | 14.88 Billion USD | 10.52% |
| 2005 | 13.46 Billion USD | 0.55% |
| 2004 | 13.39 Billion USD | 24.43% |
| 2003 | 10.76 Billion USD | 7.15% |
| 2002 | 10.04 Billion USD | 9.12% |
| 2001 | 9.2 Billion USD | 46.49% |
| 2000 | 6.28 Billion USD | 30.21% |
| 1999 | 4.82 Billion USD | 106.6% |
| 1998 | 2.33 Billion USD | 31.5% |
| 1997 | 1.77 Billion USD | 1.48% |
| 1996 | 1.75 Billion USD | 35.31% |
| 1995 | 1.29 Billion USD | 25.95% |
| 1994 | 1.02 Billion USD | 156.2% |
| 1993 | 400.9 Million USD | 12.2% |
| 1992 | 357.3 Million USD | 41.23% |
| 1991 | 253 Million USD | 100.32% |
| 1990 | 126.3 Million USD | -23.36% |
| 1989 | 164.8 Million USD | 20.73% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 48.33 Billion USD | -1.65% |
| 2024 FY | 48.33 Billion USD | 4.47% |
| 2024 Q2 | 50.02 Billion USD | 5.97% |
| 2024 Q1 | 47.2 Billion USD | 2.01% |
| 2024 Q3 | 49.14 Billion USD | -1.76% |
| 2023 Q1 | 45.16 Billion USD | 1.31% |
| 2023 Q3 | 45.59 Billion USD | -2.35% |
| 2023 Q2 | 46.69 Billion USD | 3.38% |
| 2023 Q4 | 46.26 Billion USD | 1.48% |
| 2023 FY | 46.26 Billion USD | 3.78% |
| 2022 Q1 | 41.59 Billion USD | -2.49% |
| 2022 Q4 | 44.58 Billion USD | 4.16% |
| 2022 Q3 | 42.8 Billion USD | 0.3% |
| 2022 Q2 | 42.67 Billion USD | 2.6% |
| 2022 FY | 44.58 Billion USD | 4.51% |
| 2021 FY | 42.65 Billion USD | 9.46% |
| 2021 Q1 | 40.3 Billion USD | 3.41% |
| 2021 Q3 | 42.08 Billion USD | -1.55% |
| 2021 Q4 | 42.65 Billion USD | 1.38% |
| 2021 Q2 | 42.74 Billion USD | 6.06% |
| 2020 Q4 | 38.97 Billion USD | -2.42% |
| 2020 Q1 | 38.27 Billion USD | 10.52% |
| 2020 Q2 | 40.04 Billion USD | 4.61% |
| 2020 Q3 | 39.94 Billion USD | -0.24% |
| 2020 FY | 38.97 Billion USD | 12.53% |
| 2019 FY | 34.63 Billion USD | 2.19% |
| 2019 Q2 | 34.41 Billion USD | 0.94% |
| 2019 Q3 | 34.57 Billion USD | 0.46% |
| 2019 Q1 | 34.09 Billion USD | 0.61% |
| 2019 Q4 | 34.63 Billion USD | 0.16% |
| 2018 Q4 | 33.89 Billion USD | 1.19% |
| 2018 Q1 | 35.24 Billion USD | 5.89% |
| 2018 Q3 | 33.49 Billion USD | -5.08% |
| 2018 Q2 | 35.28 Billion USD | 0.12% |
| 2018 FY | 33.89 Billion USD | 1.83% |
| 2017 Q2 | 28.68 Billion USD | 2.89% |
| 2017 Q4 | 33.28 Billion USD | 20.99% |
| 2017 Q3 | 27.5 Billion USD | -4.08% |
| 2017 Q1 | 27.87 Billion USD | 1.18% |
| 2017 FY | 33.28 Billion USD | 20.81% |
| 2016 Q1 | 24.69 Billion USD | 3.39% |
| 2016 FY | 27.55 Billion USD | 15.34% |
| 2016 Q3 | 27.32 Billion USD | 2.04% |
| 2016 Q4 | 27.55 Billion USD | 0.83% |
| 2016 Q2 | 26.77 Billion USD | 8.44% |
| 2015 FY | 23.88 Billion USD | 21.67% |
| 2015 Q3 | 21.51 Billion USD | 1.75% |
| 2015 Q1 | 19.45 Billion USD | -0.9% |
| 2015 Q2 | 21.14 Billion USD | 8.7% |
| 2015 Q4 | 23.88 Billion USD | 11.0% |
| 2014 Q3 | 18.16 Billion USD | -1.36% |
| 2014 FY | 19.63 Billion USD | -1.07% |
| 2014 Q4 | 19.63 Billion USD | 8.05% |
| 2014 Q1 | 17.51 Billion USD | -11.72% |
| 2014 Q2 | 18.42 Billion USD | 5.14% |
| 2013 Q3 | 19.89 Billion USD | 9.91% |
| 2013 Q4 | 19.84 Billion USD | -0.25% |
| 2013 FY | 19.84 Billion USD | 10.15% |
| 2013 Q1 | 18.53 Billion USD | 2.9% |
| 2013 Q2 | 18.1 Billion USD | -2.37% |
| 2012 FY | 18.01 Billion USD | 5.99% |
| 2012 Q4 | 18.01 Billion USD | -2.1% |
| 2012 Q3 | 18.4 Billion USD | 0.36% |
| 2012 Q1 | 17.46 Billion USD | 2.78% |
| 2012 Q2 | 18.33 Billion USD | 4.96% |
| 2011 Q3 | 17.54 Billion USD | 0.64% |
| 2011 Q2 | 17.42 Billion USD | 10.77% |
| 2011 Q1 | 15.73 Billion USD | 6.93% |
| 2011 Q4 | 16.99 Billion USD | -3.09% |
| 2011 FY | 16.99 Billion USD | 15.52% |
| 2010 Q3 | 15.9 Billion USD | 2.01% |
| 2010 Q4 | 14.71 Billion USD | -7.51% |
| 2010 Q1 | 15.49 Billion USD | -5.49% |
| 2010 FY | 14.71 Billion USD | -10.25% |
| 2010 Q2 | 15.59 Billion USD | 0.66% |
| 2009 Q2 | 16.88 Billion USD | 0.96% |
| 2009 Q3 | 17.1 Billion USD | 1.26% |
| 2009 Q4 | 16.39 Billion USD | -4.13% |
| 2009 FY | 16.39 Billion USD | 4.42% |
| 2009 Q1 | 16.72 Billion USD | 6.54% |
| 2008 FY | 15.7 Billion USD | -0.48% |
| 2008 Q1 | 15.92 Billion USD | 0.97% |
| 2008 Q2 | 16.35 Billion USD | 2.69% |
| 2008 Q3 | 16.21 Billion USD | -0.91% |
| 2008 Q4 | 15.7 Billion USD | -3.14% |
| 2007 Q4 | 15.77 Billion USD | -3.93% |
| 2007 FY | 15.77 Billion USD | 6.0% |
| 2007 Q2 | 15.22 Billion USD | 1.46% |
| 2007 Q3 | 16.42 Billion USD | 7.83% |
| 2007 Q1 | 15.01 Billion USD | 0.85% |
| 2006 FY | 14.88 Billion USD | 10.52% |
| 2006 Q1 | 14.09 Billion USD | 4.64% |
| 2006 Q2 | 14.47 Billion USD | 2.75% |
| 2006 Q3 | 15.05 Billion USD | 4.0% |
| 2006 Q4 | 14.88 Billion USD | -1.16% |
| 2005 Q3 | 13.46 Billion USD | 1.77% |
| 2005 Q4 | 13.46 Billion USD | 0.01% |
| 2005 Q2 | 13.22 Billion USD | -5.84% |
| 2005 Q1 | 14.05 Billion USD | 4.91% |
| 2005 FY | 13.46 Billion USD | 0.55% |
| 2004 FY | 13.39 Billion USD | 24.43% |
| 2004 Q4 | 13.39 Billion USD | 8.87% |
| 2004 Q1 | 11.52 Billion USD | 7.09% |
| 2004 Q2 | 11.92 Billion USD | 3.47% |
| 2004 Q3 | 12.3 Billion USD | 3.15% |
| 2003 Q4 | 10.76 Billion USD | -4.21% |
| 2003 FY | 10.76 Billion USD | 7.15% |
| 2003 Q3 | 11.23 Billion USD | 5.51% |
| 2003 Q2 | 10.64 Billion USD | 7.77% |
| 2003 Q1 | 9.88 Billion USD | -1.63% |
| 2002 FY | 10.04 Billion USD | 9.12% |
| 2002 Q3 | 10.04 Billion USD | -1.33% |
| 2002 Q4 | 10.04 Billion USD | -0.02% |
| 2002 Q1 | 10.05 Billion USD | 9.19% |
| 2002 Q2 | 10.18 Billion USD | 1.31% |
| 2001 Q2 | 7.99 Billion USD | 14.3% |
| 2001 Q3 | 9.13 Billion USD | 14.31% |
| 2001 FY | 9.2 Billion USD | 46.49% |
| 2001 Q1 | 6.99 Billion USD | 11.31% |
| 2001 Q4 | 9.2 Billion USD | 0.73% |
| 2000 Q2 | 6.41 Billion USD | 11.51% |
| 2000 Q3 | 6.83 Billion USD | 6.51% |
| 2000 FY | 6.28 Billion USD | 30.21% |
| 2000 Q4 | 6.28 Billion USD | -8.08% |
| 2000 Q1 | 5.75 Billion USD | 19.28% |
| 1999 Q2 | 3.28 Billion USD | 11.78% |
| 1999 FY | 4.82 Billion USD | 106.6% |
| 1999 Q1 | 2.94 Billion USD | 25.96% |
| 1999 Q4 | 4.82 Billion USD | -7.34% |
| 1999 Q3 | 5.2 Billion USD | 58.34% |
| 1998 Q3 | 2.42 Billion USD | 13.83% |
| 1998 Q2 | 2.13 Billion USD | 13.48% |
| 1998 Q4 | 2.33 Billion USD | -3.7% |
| 1998 Q1 | 1.87 Billion USD | 5.71% |
| 1998 FY | 2.33 Billion USD | 31.5% |
| 1997 Q2 | 2.05 Billion USD | 10.92% |
| 1997 Q1 | 1.85 Billion USD | 5.75% |
| 1997 Q3 | 1.79 Billion USD | -12.68% |
| 1997 Q4 | 1.77 Billion USD | -0.93% |
| 1997 FY | 1.77 Billion USD | 1.48% |
| 1996 Q3 | 1.49 Billion USD | 4.35% |
| 1996 Q4 | 1.75 Billion USD | 16.91% |
| 1996 Q2 | 1.43 Billion USD | 4.06% |
| 1996 Q1 | 1.37 Billion USD | 6.59% |
| 1996 FY | 1.75 Billion USD | 35.31% |
| 1995 Q3 | 1.3 Billion USD | -6.88% |
| 1995 Q1 | 1.24 Billion USD | 21.33% |
| 1995 Q2 | 1.39 Billion USD | 12.28% |
| 1995 Q4 | 1.29 Billion USD | -0.71% |
| 1995 FY | 1.29 Billion USD | 25.95% |
| 1994 Q1 | 391.3 Million USD | -11.65% |
| 1994 FY | 1.02 Billion USD | 156.2% |
| 1994 Q4 | 1.02 Billion USD | 1.92% |
| 1994 Q2 | 491.6 Million USD | 25.63% |
| 1994 Q3 | 1 Billion USD | 105.0% |
| 1993 Q4 | 442.9 Million USD | 10.48% |
| 1993 Q2 | 457 Million USD | 17.36% |
| 1993 Q1 | 389.4 Million USD | 1.43% |
| 1993 FY | 400.9 Million USD | 12.2% |
| 1993 Q3 | 400.9 Million USD | -12.28% |
| 1992 Q3 | 357.3 Million USD | -15.51% |
| 1992 Q1 | 321.3 Million USD | 20.11% |
| 1992 Q2 | 422.9 Million USD | 31.62% |
| 1992 FY | 357.3 Million USD | 41.23% |
| 1992 Q4 | 383.9 Million USD | 7.44% |
| 1991 Q1 | 237.4 Million USD | 12.73% |
| 1991 Q3 | 253 Million USD | -9.58% |
| 1991 Q4 | 267.5 Million USD | 5.73% |
| 1991 FY | 253 Million USD | 100.32% |
| 1991 Q2 | 279.8 Million USD | 17.86% |
| 1990 Q4 | 210.6 Million USD | 66.75% |
| 1990 Q3 | 126.3 Million USD | -13.85% |
| 1990 Q2 | 146.6 Million USD | 0.0% |
| 1990 FY | 126.3 Million USD | -23.36% |
| 1989 Q3 | 164.8 Million USD | 0.0% |
| 1989 FY | 164.8 Million USD | 20.73% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -40300.047% |
| Accuray Incorporated | 423.54 Million USD | -11311.592% |
| Align Technology, Inc. | 2.45 Billion USD | -1870.051% |
| Elevance Health Inc. | 69.52 Billion USD | 30.479% |
| AxoGen, Inc. | 101.16 Million USD | -47677.822% |
| Boston Scientific Corporation | 15.6 Billion USD | -209.708% |
| CVS Health Corporation | 173.09 Billion USD | 72.077% |
| Centene Corporation | 58.68 Billion USD | 17.64% |
| DaVita Inc. | 14.87 Billion USD | -224.903% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 12.362% |
| Hologic, Inc. | 4.02 Billion USD | -1100.522% |
| Humana Inc. | 30.74 Billion USD | -57.196% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -2622.38% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -447.088% |
| Masimo Corporation | 1.67 Billion USD | -2782.627% |
| McKesson Corporation | 69.04 Billion USD | 29.995% |
| Patterson Companies, Inc. | 1.89 Billion USD | -2450.554% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -535.626% |
| ResMed Inc. | 2 Billion USD | -2306.601% |
| Henry Schein, Inc. | 5.42 Billion USD | -791.753% |
| Teladoc Health, Inc. | 2.06 Billion USD | -2239.113% |
| Universal Health Services, Inc. | 8.15 Billion USD | -492.684% |
| Veeva Systems Inc. | 1.26 Billion USD | -3717.483% |
| Baxter International Inc. | 19.8 Billion USD | -144.007% |
| Becton, Dickinson and Company | 26.98 Billion USD | -79.117% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -2264.397% |
| Danaher Corporation | 30.99 Billion USD | -55.923% |
| Stryker Corporation | 21.31 Billion USD | -126.713% |
| Medtronic plc | 39.56 Billion USD | -22.173% |